Skip to content

CagA promotes early stage of intestinal metaplasia via inhibiting the ubiquitination of telomerase reverse transcriptase

CagA promotes early stage of intestinal metaplasia via inhibiting the ubiquitination of telomerase reverse transcriptase

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065670
Enrollment
Unknown
Registered
2022-11-11
Start date
2022-11-11
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric mucosal precancerous lesions

Interventions

Non-atrophic gastritis group:Three pieces of gastric mucosal tissue, one drop of fingertip blood, and 10g of stool samples were collected
Atrophic gastritis with intestinal metaplasia group:Three pieces of gastric mucosal tissue, one drop of fingertip blood, and 10g of stool samples were collected

Sponsors

Xinqiao Hospital, Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 30-75 years old; 2. Gender: male or female; 3. Diagnostic criteria: endoscopic diagnosis of atrophic gastritis with intestinal metaplasia or chronic non-atrophic gastritis; 4. Patients voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: 1. Cardiovascular diseases, coagulation disorders, metabolic diseases and mental diseases (hypertension, diabetes, depression, etc.); 2. Taking antibiotics or probiotics in the past 3 months; 3. History of alcoholism, smoking and other tumors; 4. Those who are pregnant or lactating; 5. Previous history of esophageal or gastrointestinal surgery; 6. Other reasons are not suitable for painless endoscopy; 7. Persons who refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
The HE dye;Carbon 13 breath test system;Rapid urea's test;Serum antibodies against Helicobacter pylori bacilli;untoward effect;

Secondary

MeasureTime frame
Helicobacter pylori bacillus antigen in stool;qPCR;Detection of CagA in gastric mucosal DNA;Immunofluorescence staining;

Countries

China

Contacts

Public ContactYang shiming

Xinqiao Hospital, Army Military Medical University

13228686589@163.com+86 13228686589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026